Envestnet Asset Management Inc Ab Cellera Biologics Inc. Transaction History
Envestnet Asset Management Inc
- $324 Billion
- Q3 2025
A detailed history of Envestnet Asset Management Inc transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 15,914 shares of ABCL stock, worth $58,722. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,914
Previous 18,310
13.09%
Holding current value
$58,722
Previous $62,000
29.03%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ABCL
# of Institutions
163Shares Held
98.9MCall Options Held
1.26MPut Options Held
788K-
Baker Bros. Advisors LP New York, NY27.5MShares$102 Million1.13% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$49.3 Million0.01% of portfolio
-
Two Sigma Investments, LP New York, NY5.18MShares$19.1 Million0.04% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny4.8MShares$17.7 Million0.05% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$16.8 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.05B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...